DanielJosephDorganMD
Pulmonology • Philadelphia, PACritical Care Medicine, Cystic Fibrosis, Infectious Disease
Assistant Professor of Clinical Medicine, University of Pennsylvania
Dr. Dorgan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
Harron Lung Center, University of Pennsylvania
Philadelphia, PA 19104Phone+1 215-662-3202
Summary
- Dr. Dan Dorgan is a pulmonologist in Philadelphia, PA and is affiliated with Hospital of the University of Pennsylvania. He received his medical degree from University of Michigan Medical School and has been in practice 13 years. He specializes in pulmonary and critical care medicine, and is experienced in cystic fibrosis, primary ciliary dyskinesia, bronchiectasis, non-TB mycobacterial infections, critical care medicine, chronic obstructive pulmonary disease, and general pulmonology.
Education & Training
University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
University of Michigan Medical SchoolClass of 2004
Certifications & Licensure
FL State Medical License 2023 - Present
NJ State Medical License 2022 - 2025
PA State Medical License 2008 - 2024
NY State Medical License 2006 - 2009- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects Start of enrollment: 2018 Dec 07
- Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex Start of enrollment: 2021 Apr 01
- 4D-710 in Adult Patients With Cystic Fibrosis Start of enrollment: 2022 Mar 29
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsImpact of novel CFTR modulator on sinonasal quality of life in adult patients with cystic fibrosis.Jennifer E. Douglas, Alyssa M. Civantos, Tran B. Locke, Auddie M. Sweis, Denis Hadjiliadis
International Forum of Allergy & Rhinology. 2021-02-01 - 43 citationsT2R38 genotype is correlated with sinonasal quality of life in homozygous ΔF508 cystic fibrosis patientsNithin D. Adappa, Alan D. Workman, Denis Hadjiliadis, Daniel Dorgan, Danielle Frame
International Forum of Allergy & Rhinology. 2016-04-01 - 7 citationsSelf-reactive CFTR T cells in humans: implications for gene therapy.Roberto Calcedo, Uta Griesenbach, Daniel Dorgan, Samia Soussi, A. Christopher Boyd
Human Gene Therapy. Clinical Development. 2013-06-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
